Pain Task Force
Task Force
Pain
CenExel’s Pain Task Force brings together the industry’s leading experts in post-operative acute pain and chronic pain research — driving faster enrollments, higher data quality, and more successful trials.
Task Force Highlights
40+
Years of pain research experience
15,000+
Participants in analgesia trials
18
Centers of Excellence across the U.S.
Leading Pain Clinical Research
Complex pain conditions require specialized scientific and operational expertise. CenExel’s dedicated pain research teams include experienced investigators, clinical staff, and participant-focused support systems—ensuring efficient and high-quality trial execution.
Our sites are equipped to conduct early and late-phase pain studies, utilizing advanced methodologies and validated endpoints to measure treatment effectiveness.
We support a wide range of pain conditions, including neuropathic, musculoskeletal, and inflammatory pain—across adult and geriatric populations.
Pain Conditions We Research
Our research sites support a broad spectrum of pain conditions — from chronic back pain and neuropathic pain to rare and treatment-resistant pain disorders.
Chronic Pain
Neuropathic Pain
Migraine Disorders
Lower Back Pain
Fibromyalgia
Osteoarthritis Pain
Post-Surgical Pain
Cancer-Related Pain
Complex Regional Pain Syndrome (CRPS)
Diabetic Neuropathy
Rheumatoid Arthritis Pain
Why Sponsors Choose CenExel for Pain
CenExel’s expertise in pain research goes beyond recruitment—we provide scientific insight, operational excellence, and reliable data outcomes.
01
Expert Pain Assessment
Our investigators use validated pain scales and clinical endpoints to ensure accurate and consistent data collection.
02
Innovative Trial Design
We implement adaptive trial designs and biomarker strategies to improve study efficiency and outcomes.
03
Diverse Participant Access
Access to diverse participant populations across multiple sites ensures representative and reliable results.
04
Proven Enrollment Success
Our recruitment strategies consistently meet or exceed enrollment targets for pain studies.
Supported Trial Phases
CenExel supports early and late-phase pain research—from first-in-human and proof-of-concept studies through Phase IV post-market trials.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Leader
Pain Task Force
CenExel supports a wide range of pain-related indications including chronic pain, neuropathic disorders, inflammatory conditions, and post-operative pain. Our specialized teams focus on delivering precise, participant-centered research across diverse populations.
Active Sites
15 Sites
Also in Pain & Related Areas
Therapeutic Area
Neurology
Neurological conditions impacting pain pathways and nerve function.
Therapeutic Area
Inflammation & Arthritis
Conditions involving chronic inflammation and joint-related pain.
Therapeutic Area
Sleep Disorders
Sleep disturbances often associated with chronic pain conditions.
